Shanghai, China

Kun Zeng

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 1990-2025

Loading Chart...
5 patents (USPTO):

Title: Innovations of Kun Zeng

Introduction

Kun Zeng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of optical observation and pharmaceutical compositions. With a total of five patents to his name, Zeng's work focuses on advancing medical technology and treatment methods.

Latest Patents

Zeng's latest patents include innovative optical observation equipment designed for identifying the forming process of malignant tumors. This equipment features a receiving space and a transparent front end, incorporating a light-guide fiber, a laser emitter, a focusing device, a white light emitter, an image sensor, a high gain amplifier, and an encoding and emitting device. The laser emitter operates at a wavelength of 340 nm±20 nm and an energy of 0.3 to 0.5 mj/min in a pulsing mode. The alternating use of the laser and white light emitters allows for detailed imaging of the area being observed. Additionally, Zeng has developed an aromatic heterocyclic compound that serves as a new ALK5 inhibitor, aimed at treating and preventing various ALK5-mediated diseases.

Career Highlights

Throughout his career, Kun Zeng has worked with notable companies, including Shanghai Yingli Pharmaceutical Co., Ltd. His expertise in the pharmaceutical field has led to the development of groundbreaking technologies and compounds that have the potential to improve patient outcomes.

Collaborations

Zeng has collaborated with esteemed colleagues such as Zhenfen Yu and Zusheng Xu. Their combined efforts have contributed to the advancement of innovative solutions in the medical and pharmaceutical sectors.

Conclusion

Kun Zeng's contributions to innovation in optical observation and pharmaceutical development highlight his role as a leading inventor. His patents reflect a commitment to improving medical technology and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…